Scribe Biosciences is an early stage startup borne from a research collaboration between Adam Abate and Zev Gartner's labs at the UCSF to develop robust and scaleable single cell technologies.
WHAT WE DO
Our fundamental technology, Printed Droplet Microfluidics (PDM), is a flexible and reconfigurable fluid handling system to perform picoliter-scale manipulations. By leveraging fluorescence-activated microfluidic droplet sorting and a specialized substrate, PDM enables the flexible and deterministic handling of single cells and fluid aliquots at extremely high throughputs.
Scribe is currently working under a SBIR research contract from the DARPA INTERCEPT program to adapt PDM technology for single cell virology applications.
953 Indiana St